Filing Details

Accession Number:
0001209191-17-066250
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-19 08:56:30
Reporting Period:
2017-12-18
Accepted Time:
2017-12-19 08:56:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1445283 Proteostasis Therapeutics Inc. PTI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219855 James M Barrett 1954 Greenspring Drive
Suite 600
Timonium MD 21093
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-18 2,000,000 $5.00 5,554,610 No 4 P Indirect See Note 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 1
Footnotes
  1. The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 12 in which the Reporting Person has no pecuniary interest.